INSIGHTS
A Conversation on Bridging Perspectives in Health Care
“Progress depends on the ability to engage with people whose perspectives differ from our own.” We recently spoke with Jennifer Mandel, a member of Reservoir’s Advocacy and Alliance Network, about what it means
New CMMI Models, New Questions for Part D and Patients
Federal drug pricing policy is evolving at an extraordinary pace. With implementation of the Inflation Reduction Act (IRA) well underway and the recent announcements of new Center for
Immunology Beyond the Lab: Why Breakthrough Science Alone Isn’t Enough
Immunology is shaping one of the most dynamic areas of modern medicine. From autoimmune and inflammatory diseases – like atopic dermatitis, ulcerative colitis and Crohn’s
Building Coalitions that Shape Smarter Health Care Legislation
Advancing health policies that improve outcomes and meet the moment requires careful leadership and collaboration. The journey from identifying an issue that needs to be
Explaining Price in a Multi-Price World: What TrumpRx and Populist Pressure Mean for Pharma
For more than two decades, the dominant paradigm for explaining pharmaceutical pricing has been value. That value was defined by clinical benefit, improved patient outcomes or experience, and
Are We at a Turning Point in Obesity Care?
November 2025 may ultimately be remembered as a pivotal moment in how the United States understands and treats obesity. Last month, federal regulators announced an